<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 1985, plasma cholesterol, <z:chebi fb="0" ids="17855">triglyceride</z:chebi>, <z:chebi fb="1" ids="47775">high-density lipoprotein cholesterol</z:chebi>, and plasma <z:chebi fb="0" ids="13850">apoprotein</z:chebi> (apo) B levels were measured in 2,103 men (aged 45 to 76 years) without <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> from the Qu√©bec city suburbs </plain></SENT>
<SENT sid="1" pm="."><plain>Occurrence of a first ischemic event (i.e., <z:hpo ids='HP_0001681'>angina pectoris</z:hpo>, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, or coronary-related <z:hpo ids='HP_0011420'>death</z:hpo>) was recorded in 114 men between 1985 and 1990 </plain></SENT>
<SENT sid="2" pm="."><plain>Men with and without <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> were classified as <z:mpath ids='MPATH_458'>normal</z:mpath> or in various dyslipidemic groups according to an established algorithm </plain></SENT>
<SENT sid="3" pm="."><plain>Of the 1,989 men who remained free of ischemic events, 50% had a <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="23" ids="18059">lipid</z:chebi> profile compared with 32% in men with <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Although the prevalence of type IIb and IV <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemias</z:e> was similar in men with and without <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, type IIa (16% vs 10%), hyperapo B-<z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> (12% vs 6%), hyperapo B-normotriglyceridemia (11% vs 7%), and <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> (18% vs 13%) were more prevalent in men with than without <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Adjusted odds ratios (ORs) were not increased in type IIb and IV phenotypes, whereas men with type IIa (OR 2.8), with the 2 hyperapo B phenotypes (hyperapo B-normotriglyceridemia, OR 2.7; hyperapo B-<z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo>, OR 3.1) or with isolated <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> (OR 2.2), were at higher risk </plain></SENT>
<SENT sid="6" pm="."><plain>The results of this prospective study confirm the importance of both elevated plasma cholesterol and decreased <z:chebi fb="1" ids="47775">high-density lipoprotein cholesterol</z:chebi> levels as risk factors for <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>They also emphasize the high prevalence of an elevated apo B dyslipidemic state in <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> </plain></SENT>
</text></document>